Chat with Özlem Türeci AI

Physician, scientist, and co-founder of BioNTech

AI character, not a real person. Chat with Özlem Türeci AI free with an account, or call and hear the answer out loud.

About Özlem Türeci

Long before the world knew the name BioNTech, Özlem Türeci was working on a simple but stubborn idea: the immune system could be taught to recognize a patient's own tumor. Her path ran through clinical medicine and laboratory immunology in Saarland and Mainz, where she spent years studying how T cells respond to cancer antigens. That work led to Ganymed Pharmaceuticals, a company focused on antibody therapies that target proteins found on tumor cells, and a pipeline that was later acquired by a larger drugmaker. In 2008 she and Uğur Şahin founded BioNTech to pursue messenger RNA as a platform for individualized medicine. When COVID-19 emerged, that platform was ready to be tested at speed, and the team's mRNA vaccine became one of the first to reach the public. Türeci has remained a forceful voice for personalized cancer vaccines, arguing that therapies built around each patient's tumor mutations should move from research papers into everyday oncology.

Why Chat with Özlem Türeci?

Özlem Türeci is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on physician, scientist, and co-founder of biontech topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.

Start Your Conversation with Özlem Türeci

Ask questions, explore ideas, and learn something new. Free with an account, and no card.

Chat with Özlem Türeci Now

Call Özlem Türeci and talk out loud

You do not have to type. Call Özlem Türeci and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.

Call Özlem Türeci How calling works

Conversation Starters

Not sure where to begin? Try asking Özlem Türeci:

  • “How did your work on antibody therapies at Ganymed shape the path to BioNTech?”
  • “Why do you think individualized tumor vaccines are harder to scale than mRNA infection vaccines?”
  • “What did the early mRNA platform look like before COVID-19 changed its priorities?”
  • “How should clinicians decide which tumor mutations to target in a personalized vaccine?”

Frequently Asked Questions

What did Özlem Türeci contribute to BioNTech?
Türeci co-founded BioNTech in 2008 with Uğur Şahin, building the company around messenger RNA for individualized cancer immunotherapy. She has served in senior leadership roles, including overseeing medical and clinical development. Her background in clinical medicine and tumor immunology helped steer the company's focus toward patient-specific treatments. The COVID-19 vaccine developed with Pfizer grew out of that same platform.
Where did Özlem Türeci train as a physician and scientist?
She studied medicine in Germany and completed her training with a strong emphasis on immunology and oncology. Much of her early research took place in Saarland, where she worked on how the immune system recognizes tumor antigens. That foundation in both clinical practice and laboratory science shaped her later focus on translating immunology into therapies. Her career combines hands-on medicine with the drug development process.
What is Ganymed Pharmaceuticals and why does it matter?
Ganymed Pharmaceuticals was a Mainz-based biotech company that Türeci helped found to develop antibody-based cancer therapies. Its work centered on targets expressed on tumor cells, aiming to attack cancer while sparing healthy tissue. The company's lead program was later acquired by a major pharmaceutical firm, which carried it through late-stage development. The venture showed how targeted antibodies and mRNA-based approaches could sit side by side in one oncology strategy.
What is Özlem Türeci's view on personalized cancer therapy?
Türeci argues that every tumor carries its own set of mutations, so treatment should be tailored to the specific genetic profile of each patient. She has advocated for individualized mRNA cancer vaccines that train the immune system to target those mutations. In her view, the tools developed during the COVID-19 response could accelerate this kind of care. She has consistently pushed for these approaches to move from experimental trials into routine clinical practice.
Can I call Özlem Türeci and talk out loud?
Yes. Every character on AI Anyone can be called, including Özlem Türeci. You talk, they answer in their own voice, and you can interrupt them by tapping the screen. Calling runs in a web browser on a phone or a laptop with no app to install, and it needs a free account: signing in gives you 20 minutes of calls at no cost every 30 days. Pro includes 240 minutes every 30 days.

Topics

medicineimmunologycancervaccinesscience

Related Science & Technology Characters

August von Wassermann
German Physician and Immunologist
Karl Landsteiner
Father of Blood Grouping
Michael Houghton
Virologist and Nobel Laureate
Harald zur Hausen
Nobel Laureate Virologist
Max Theiler
Virologist and Nobel Laureate
Louis Pasteur
Chemist and Microbiologist
Paul Ehrlich
Pioneer of Chemotherapy and Immunology
Baruj Benacerraf
Immunologist and Nobel Laureate
Browse all Science & Technology characters →
Explore 39,762 AI Characters →
© 2026 AI Anyone. All rights reserved.